WELL Health Technologies Corp.
WHTCF
$2.71
$0.020.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 54.21% | 55.18% | 23.64% | -18.78% | 12.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.21% | 55.18% | 23.64% | -18.78% | 12.61% |
| Cost of Revenue | 41.15% | 44.19% | 28.31% | 13.52% | 24.45% |
| Gross Profit | 73.44% | 71.49% | 17.22% | -60.41% | -1.23% |
| SG&A Expenses | 35.54% | 43.75% | 10.96% | -5.92% | 7.84% |
| Depreciation & Amortization | 50.27% | 45.12% | 10.88% | 21.59% | 11.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.01% | 44.12% | 21.20% | 7.33% | 17.49% |
| Operating Income | 3,098.42% | 33,508.21% | 142.58% | -1,085.42% | -88.63% |
| Income Before Tax | 107.41% | -77.14% | -457.07% | -242.78% | -1,913.27% |
| Income Tax Expenses | 346.39% | 191.64% | 52.69% | -2,403.15% | -15,048.39% |
| Earnings from Continuing Operations | 97.03% | -84.08% | -385.48% | -191.33% | -1,840.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 500.39% | -154.45% | -57.73% | 405.91% | 46.86% |
| Net Income | 104.58% | -88.41% | -498.07% | -145.44% | -1,065.13% |
| EBIT | 3,098.42% | 33,508.21% | 142.58% | -1,085.42% | -88.63% |
| EBITDA | 228.77% | 191.13% | 38.98% | -525.84% | -26.54% |
| EPS Basic | 104.48% | -88.73% | -486.87% | -148.82% | -1,015.97% |
| Normalized Basic EPS | 283.61% | 128.23% | 19.26% | -329.48% | -146.46% |
| EPS Diluted | 104.48% | -88.42% | -495.22% | -157.29% | -1,015.97% |
| Normalized Diluted EPS | 281.15% | 128.98% | 15.81% | -329.48% | -146.46% |
| Average Basic Shares Outstanding | 1.95% | 2.85% | 3.03% | -6.90% | 4.49% |
| Average Diluted Shares Outstanding | 3.38% | 0.91% | -1.09% | -6.90% | 4.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |